REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

"Vetoquinol Biowet" Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Animal Food Manufacturing | Adhesive Manufacturing | Explosives Manufacturing | All Other Chemical Product and Preparation Manufacturing | All Other Fabricated Metal Product Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: "Vetoquinol Biowet" Sp. z o.o. Profile Updated: January 03, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

"Vetoquinol Biowet" Sp. z o.o is a company in the veterinary industry, offering natural supplementary food, complementary food, and medication for dogs, cats, and horses. Their products include Zylkene, Ipakitine, MEGA BASE, Dolpac tablets, and Drontal.

Headquarters
Ul. Kosynierow Gdynskich 13/14
Gorzow Wielkopolski; Lubuskie; Postal Code: 66-400

Contact Details: Purchase the "Vetoquinol Biowet" Sp. z o.o. report to view the information.

Website: http://www.vetoquinol.pl

Basic Information
Total Employees:
Purchase the "Vetoquinol Biowet" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Vetoquinol Biowet" Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the "Vetoquinol Biowet" Sp. z o.o. report to view the information.
Incorporation Date:
November 20, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
99.97%
Company Performance
Financial values in the chart are available after "Vetoquinol Biowet" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
12.23%▲
Total operating revenue
12.75%▲
Operating profit (EBIT)
69.41%▲
EBITDA
155.23%▲
Net Profit (Loss) for the Period
-212.76%▼
Total Assets
6.18%▲
Total Equity
-5.5%▼
Operating Profit Margin (ROS)
1.72%▲
Net Profit Margin
-1.09%▼
Return on Equity (ROE)
-4.06%▼
Quick Ratio
-0.03%▼

Similar companies

Synoptis Pharma Sp. z o.o.
 
Zaklady Farmaceutyczne "Polpharma" S.A.
Lek S.A.
 
Teva Operations Poland Sp. z o.o.
Adamed Pharma S.A.
 
Aflofarm Farmacja Polska Sp. z o.o.
"Us Pharmacia" Sp. z o.o.
 
Verco S.A.
Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. (Sp. z o.o.) Oddzial W Polsce
 
Zaklady Farmaceutyczne "Unia" Spoldzielnia Pracy
Instytut Biotechnologii Surowic I Szczepionek Biomed S.A. - Skrot Firmy Ibss Biomed S.A.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo